Figure 3. Breakdown of therapeutic areas covered by seed or series A financing (I) and public-private partnerships in 2011 (II). For (I), percentages are out of total financing events across all therapeutic areas; bracketed values are the actual number of companies that received financing for a given therapeutic area. For (II), percentages are out of the total number of public-private partnerships worldwide; bracketed values are actual numbers.